PF-08653945

N/A

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NamePF-08653945
Drug Alias NameMET-233iMET-233PF-08653945PF'3945
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIslet amyloid polypeptide modulators
TargetsIslet amyloid polypeptide
Therapy Area/IndicationsOverweightBody WeightObesity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMetsera Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetsera IncPfizer Inc
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[5] 
Inactive IndicationsNutritional and Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A